Hemoglobinopathy Market Size, Share, Growth, and Regional Forecast, 2026 - 2033

Hemoglobinopathy Market by Diagnostic Test (Routine Red Blood Cell (RBC) Count, Genetic Testing, Hemoglobin by High Performance Liquid Chromatography, Hemoglobin Isoelectric Focusing (Hb IEF), Hemoglobin Electrophoresis (Hb ELP), Hemoglobin Solubility Test), Indication, End-user, and Regional Analysis from 2026 - 2033

ID: PMRREP10007| 199 Pages | 24 Dec 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Hemoglobinopathy Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Diagnostic Test Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Hemoglobinopathy Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
    3. Global Hemoglobinopathy Market Outlook: Diagnostic Test
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
        1. Routine Red Blood Cell (RBC) Count
        2. Genetic Testing
        3. Hemoglobin by High Performance Liquid Chromatography
        4. Hemoglobin Isoelectric Focusing (Hb IEF)
        5. Hemoglobin electrophoresis (Hb ELP)
        6. Hemoglobin Solubility Test
      4. Market Attractiveness Analysis: Diagnostic Test
    4. Global Hemoglobinopathy Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
        1. Sickle Cell Disease
        2. Thalassemia
        3. Others
      4. Market Attractiveness Analysis: Indication
    5. Global Hemoglobinopathy Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
        1. Hospitals & Clinics
        2. Diagnostic Centers
        3. Others
      4. Market Attractiveness Analysis: End User
  5. Global Hemoglobinopathy Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  7. Europe Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  8. East Asia Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  10. Latin America Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  11. Middle East & Africa Hemoglobinopathy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Diagnostic Test
      3. By Indication
      4. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2026-2033
      1. Routine Red Blood Cell (RBC) Count
      2. Genetic Testing
      3. Hemoglobin by High Performance Liquid Chromatography
      4. Hemoglobin Isoelectric Focusing (Hb IEF)
      5. Hemoglobin Electrophoresis (Hb ELP)
      6. Hemoglobin Solubility Test
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Sickle Cell Disease
      2. Thalassemia
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Sebia
      3. Hemex Health
      4. ShanMukha Innovations Pvt Ltd
      5. Revvity
      6. Trivitron Healthcare
      7. TrueHb
      8. HiMedia Laboratories
      9. SYnAbs S.A.
      10. Alpine Biomedicals Pvt. Ltd.
      11. BIOSENSE SRL
      12. Bio Lab Diagnostics (I) Private Limited
      13. Trinity Biotech
      14. Abcam Limited (Danaher)
      15. BIOMEDOMICS INC.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate